Dry Eye Syndrome Market Players:
- Lumenis Be Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson & Johnson Services Inc.
- Alcon Vision LLC
- Allergan (AbbVie)
- Novartis AG
- Allostera Pharma Inc.
- I-Med Pharma Inc.
- Acadia Pharmaceutical Inc.
- Otsuka Pharmaceutical Co. Ltd.
- Sun Pharmaceutical Industries Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of dry eye syndrome is evaluated at USD 6.75 billion.
The global dry eye syndrome market size was worth around USD 6.4 billion in 2025 and is set to register a CAGR of around 6.1%, exceeding USD 11.57 billion revenue by 2035.
North America dry eye syndrome market will secure around 40.8% share by 2035, driven by a high number of dry eye sufferers and increasing use of eye drops.
Key players in the market include Lumenis Be Ltd., Johnson & Johnson Services Inc., Alcon Vision LLC, Allergan (AbbVie), Novartis AG, Allostera Pharma Inc., I-Med Pharma Inc., Acadia Pharmaceutical Inc., Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd.
